Clinical Trial Update: A Study of High-Risk Oral Cavity Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial studying high-risk oral cavity cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Cancer

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Oral Cavity Cancer | Phase 2, Phase 3 | Status: TERMINATED